Clinical trial

GIOTRIF rPMS in Korean Patients With NSCLC

NCT02285361

StatusCOMPLETED

Study typeOBSERVATIONAL

Start date2014-10-31

PhaseN/A

Study timeline

Study start (actual)2014-10-31Date precision: day

Registry last updated2021-02-24

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Carcinoma, Non-Small-Cell Lungunresolved

Interventions

GIOTRIF 20mgDRUG

GIOTRIF 40mgDRUG

GIOTRIF 30mgDRUG

Sponsors & collaborators

Boehringer Ingelheimlead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT02285361 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.